| Phase 05 trials |
|
Phase 0
|
NCT04390009 |
Sep 2024 → Sep 2025 overdue |
multiple sclerosis |
Brain Health Alliance |
Recruiting
|
No outcome recorded
|
|
Phase 0
|
NCT04926259 |
Nov 2021 → Dec 2024 |
neurodegenerative disease |
First Affiliated Hospital of Fujian Medical University |
Unknown
|
No outcome recorded
|
|
Phase 0
|
NCT03080051 |
Aug 2016 → Mar 2017 |
Alzheimer disease, progressive supranuclear palsy |
Molecular NeuroImaging |
Completed
|
No outcome recorded
|
|
Phase 0
|
NCT03071224 |
Jun 2016 → Jun 2021 |
Alzheimer disease |
Invicro |
Completed
|
No outcome recorded
|
|
Phase 0
|
NCT01565291 |
Jun 2007 → Jan 2008 |
Alzheimer disease |
Avid Radiopharmaceuticals |
Completed
|
No outcome recorded
|
| Phase 16 trials |
|
Phase 1
|
NCT05164536 |
Aug 2021 → Nov 2022 |
Alzheimer disease |
Invicro |
Completed
|
No outcome recorded
|
|
Phase 1
|
NCT02370524 |
Jan 2015 → Jan 2016 |
Alzheimer disease |
Molecular NeuroImaging |
Completed
|
No outcome recorded
|
|
Phase 1
|
NCT01660815 |
Aug 2012 → Jan 2013 |
Alzheimer disease |
Avid Radiopharmaceuticals |
Completed
|
No outcome recorded
|
|
Phase 1
|
NCT01565343 |
Apr 2008 → Apr 2009 |
Alzheimer disease |
Avid Radiopharmaceuticals |
Completed
|
No outcome recorded
|
|
Phase 1
|
NCT01565330 |
Mar → Aug 2008 |
Alzheimer disease |
Avid Radiopharmaceuticals |
Completed
|
No outcome recorded
|
|
Phase 1
|
NCT01564706 |
Oct 2007 → Jan 2008 |
Alzheimer disease |
Avid Radiopharmaceuticals |
Completed
|
No outcome recorded
|
| Phase 1/21 trial |
|
Phase 1/2
|
NCT01503944 |
Mar 2010 → Jul 2011 |
Alzheimer disease, Lewy body dementia, Parkinson disease |
Avid Radiopharmaceuticals |
Completed
|
No outcome recorded
|
| Phase 212 trials |
|
Phase 2
|
NCT07012993 |
May 2025 → Jun 2030 expected |
Alzheimer disease, cognitive impairment with or without cerebellar ataxia |
Akiva Mintz |
Recruiting
|
No outcome recorded
|
|
Phase 2
|
NCT05820191 |
Jul 2024 → Jul 2026 overdue |
glioblastoma |
Universidad Central del Caribe |
Not yet recruiting
|
No outcome recorded
|
|
Phase 2
|
NCT04305210 |
Dec 2019 → Jan 2021 |
Alzheimer disease |
Chang Gung Memorial Hospital |
Unknown
|
No outcome recorded
|
|
Phase 2
|
NCT04572477 |
Jun 2017 → Nov 2023 |
vascular dementia |
Chang Gung Memorial Hospital |
Unknown
|
No outcome recorded
|
|
Phase 2
|
NCT02079766 |
Jun 2014 → Oct 2015 |
dementia pugilistica |
Avid Radiopharmaceuticals |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT01518374 |
Dec 2009 → May 2017 |
Alzheimer disease, cognitive impairment with or without cerebellar ataxia |
Avid Radiopharmaceuticals |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT01890343 |
Sep 2009 → Dec 2012 |
Alzheimer disease, frontotemporal dementia |
Avid Radiopharmaceuticals |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT00855868 |
Mar 2009 → Jan 2011 |
Alzheimer disease |
Avid Radiopharmaceuticals |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT00857532 |
Jan 2009 → Nov 2011 |
Parkinson disease |
Avid Radiopharmaceuticals |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT00857506 |
Jan 2009 → Dec 2011 |
Alzheimer disease, cognitive impairment with or without cerebellar ataxia |
Avid Radiopharmaceuticals |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT00702143 |
Jun → Dec 2008 |
Alzheimer disease, cognitive impairment with or without cerebellar ataxia |
Avid Radiopharmaceuticals |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT00315250 |
Jan 2006 → Jan 2010 |
Parkinson disease |
Institute for Neurodegenerative Disorders |
Completed
|
No outcome recorded
|
|
| Phase 2/31 trial |
|
Phase 2/3
|
NCT01662882 |
Oct 2012 → Feb 2013 |
Alzheimer disease, cognitive impairment with or without cerebellar ataxia |
Avid Radiopharmaceuticals |
Completed
|
No outcome recorded
|
| Phase 33 trials |
|
Phase 3
|
NCT04604587 |
Oct 2020 → Jul 2023 |
cerebral amyloid angiopathy, intracerebral hemorrhage |
National Taiwan University Hospital |
Unknown
|
No outcome recorded
|
|
Phase 3
|
NCT01400425 |
Jul 2011 → Jul 2012 |
subjective cognitive decline |
Avid Radiopharmaceuticals |
Completed
|
No outcome recorded
|
|
Phase 3
|
NCT00857415 |
Dec 2008 → Mar 2010 |
Alzheimer disease |
Avid Radiopharmaceuticals |
Completed
|
No outcome recorded
|
| Phase 45 trials |
|
Phase 4
|
NCT03040427 |
Jan 2017 → Aug 2019 |
amyloidosis |
The Cleveland Clinic |
Terminated
|
No outcome recorded
|
|
Phase 4
|
NCT02051790 |
Mar → Aug 2014 |
Alzheimer disease |
Avid Radiopharmaceuticals |
Completed
|
No outcome recorded
|
|
Phase 4
|
NCT01683825 |
Mar 2013 → Oct 2018 |
amyloidosis |
Brigham and Women's Hospital |
Completed
|
No outcome recorded
|
|
Phase 4
|
NCT01767493 |
Nov 2012 → Nov 2013 |
multiple sclerosis |
Institute for Neurodegenerative Disorders |
Completed
|
No outcome recorded
|
|
Phase 4
|
NCT01703702 |
Oct 2012 → Apr 2015 |
Alzheimer disease |
Avid Radiopharmaceuticals |
Completed
|
No outcome recorded
|
| Phase not applicable1 trial |
| — |
NCT01565356 |
Mar → May 2010 |
Alzheimer disease |
Avid Radiopharmaceuticals |
Completed
|
No outcome recorded
|